FDA Inspection 1080224 — Kopran Research Laboratories Limited
The FDA completed an inspection of Kopran Research Laboratories Limited on Jan 25, 2019 in Mahad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mahad (India)